Abstract
Purpose of Review
Individuals with congenital heart disease (CHD) can experience long-term morbidities related to physical, neurodevelopmental, and psychosocial functioning. These long-term sequelae are more likely to occur for patients who meet the high-risk criteria and are associated with diminished health related quality of life (HRQOL). Understanding how to mitigate risk or intervene to improve physical, neurodevelopmental, and psychosocial outcomes for patients with CHD is critical for improving HRQOL.
Recent Findings
Instruments measuring HRQOL are available and widely used in children with CHD. Lower HRQOL is associated with greater disease complexity and medical care utilization, lower self-perception and competency, more behavioral and emotional difficulties, and greater educational impairment. Interventions like family-centered neurodevelopmental care, early intervention, psychological and behavioral services, physical activity, educational services, and family support have been shown to positively impact physical, neurodevelopmental, and psychosocial outcomes for patients with CHD, but it is unclear what interventions in these domains will specifically improve HRQOL.
Summary
There is a critical need for research focused on interventions to improve neurodevelopmental, psychosocial, and physical functioning in children with CHD. Intervention research needs to be high quality, use appropriate instruments, and should examine the impact of these interventions on HRQOL in both the short- and long-term.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Congenital heart disease (CHD) is the most common congenital malformation, impacting nearly 1% of live births worldwide [1]. A third of babies born with CHD will have complex CHD that requires surgical or catheter-based intervention within the first year of life [2]. CHD survival rates have improved dramatically in the last few decades [3], with long-term survival (> 20 years) now estimated at 80% for children with complex CHD [4]. With improving survival rates, the field has shifted to focus on reducing CHD related morbidity. Individuals with CHD, especially those who require surgical intervention in infancy, can experience long-term physical, neurodevelopmental, and psychosocial sequelae [5,6,7,8,9,10] which are strongly associated with diminished quality of life (QOL) [11, 12].
Despite recognition of the long-term impacts of these physical, neurodevelopmental, and psychosocial morbidities, little research has focused on interventions in the CHD population to mitigate these challenges to improve QOL for patients with CHD [13, 14]. This review examines research looking at the effectiveness of treatments designed to improve QOL that address physical functioning, neurodevelopmental, and/or psychosocial symptomatology in patients with CHD or other chronic illnesses.
Defining Quality of Life
QOL is a multidimensional construct that describes a child’s ability to function in a variety of contexts (e.g., at school, with peers, family life) and derive satisfaction from doing so [15,16,17]. Three domains are included in QOL: 1) physical health status and physical functioning; 2) psychological status; and 3) social functioning [15,16,17]. Health related quality of life (HRQOL) offers a more specific description of QOL for individuals with a chronic illness and can be defined as the influence of a specific illness, medical therapy, or health services policy on one’s ability to function and feel satisfaction from physical, psychological, and social contexts [18]. Within this review, we will use HRQOL for ease.
Measuring Quality of Life for Patients with CHD
Measuring HRQOL is a critical component of the evaluation of long-term outcomes for patients with CHD as it provides a comprehensive assessment of an individual’s health status, and may result in identification of physical, functional, and/or psychosocial difficulties for which interventions could be implemented [11]. Ongoing assessment of HRQOL over time offers the opportunity for patients, parents, and health care providers to monitor changes in status and evaluate the impact of any therapies or interventions that may impact HRQOL [19]. Despite the potential benefits of measuring HRQOL, assessment in pediatric populations is challenging as children’s capabilities vary significantly based on age and developmental capacity. Varying levels of CHD severity, treatment approaches, and outcomes further complicate HRQOL assessment with the pediatric CHD population [11]. Historically, measurement of HRQOL in patients with CHD has been limited, with only one published study identified as measuring patient’s perceived HRQOL between 1980 and 2000 [20], though the number of studies including HRQOL has been steadily increasing since 2000 [21].
When measuring HRQOL, both general and disease-specific instruments are available for the pediatric CHD population [22,23,24,25,26,27,28]. Generic HRQOL instruments allow for comparison of HRQOL outcomes across chronic disease groups or between chronic disease groups and healthy controls, while disease-specific HRQOL instruments are more comprehensive and better able to identify differences between sub-groups within a disease category [11]. A comprehensive review of currently available HRQOL measures for cardiac patients is available in previously published work by Marino and colleagues [11, 29]. Ideally, HRQOL measurements should assess a wide age range of patients, have both patient self- and parent/guardian proxy-reporting, and be administered easily and quickly.
HRQOL Scores in Patients with CHD
Findings from past research on the HRQOL of children and adolescents with CHD have been variable, with some studies reporting worse HRQOL and others finding similar or better HRQOL scores for patients with CHD compared to healthy controls. This variability is thought to be the result of differences in the domains of HRQOL being studied, the appropriateness of the HRQOL instrument(s) chosen to address the research question, biopsychosocial factors unique to the children and adolescents being assessed, and study-based limitations that result in underpowered analyses and/or reduce the generalizability of any findings [11].
Larger studies and systematic reviews assessing HRQOL outcomes have shown that children and adolescents with CHD have similar HRQOL scores to children with other pediatric chronic illnesses, but worse HRQOL scores compared to similar aged healthy peers [30, 31]. Despite the perception that CHD primarily has physical effects on functioning, prior research has shown that the greatest negative impact on HRQOL arises from issues in psychosocial and educational functioning [32]. Past research has also looked at HRQOL in patients with CHD by diagnosis and procedural groups, which is well summarized by Marino and colleagues [29]. Within the pediatric CHD population, patient-reported HRQOL decreases as disease complexity increases [31,32,33,34,35,36]. Specifically, children and adolescents with mild CHD not requiring any surgical or catheter-based interventions report the best HRQOL, followed by those with repaired biventricular CHD, while patients with single ventricle CHD report the worst HRQOL scores [31, 33, 35]. That HRQOL decreases as disease severity increases was also found in a large, multi-center study assessing HRQOL using a disease specific instrument by Marino and Wray [33, 34]. However, they also observed examples of single ventricle patients that had HRQOL scores as high as patients with aortic stenosis who had not undergone intervention and aortic stenosis patients with HRQOL scores as low as the average single ventricle patient, suggesting that there may be resilience and depressant factors that influence an individual’s HRQOL over time [33]. Identifying resilience and depressant factors may allow for prevention and intervention efforts to protect or improve HRQOL.
Looking at a patient’s unique medical history to understand what complications they have experienced and their health care utilization over time may provide a more nuanced understanding of HRQOL for patients with CHD [36]. For example, O’Connor and colleagues [36] utilized latent class analysis to look for group differences in HRQOL based on patient’s cardiac medical history. They found four distinct CHD complexity groups, and greater CHD complexity was associated with greater burden of illness and lower patient- and parent-reported HRQOL [36]. There are numerous, well documented surgical and perioperative factors (e.g., perioperative seizures, neurologic injury, prolonged hospitalization, mechanical support, cardiopulmonary resuscitation, heart transplantation) that can negatively impact neurodevelopmental outcomes including HRQOL [6, 7]. Lower HRQOL has also been associated with greater medical care utilization as measured by number of cardiac surgeries, cardiac-related hospital admissions, and doctor visits in the last year [33]. Similarly, behavioral, emotional, and other mental health factors can have a significant impact on HRQOL in patients with CHD. Lower HRQOL was associated with poorer patient self-perception and competency and increased behavioral and emotional problems in the pediatric cardiac population (33). Ernst and colleagues [37] found that half of the variance in HRQOL scores for patients with CHD was accounted for by factors like educational impairment, poor self-esteem, anxiety, and post-traumatic stress symptoms of both patients and their parents. Interventions that aim to reduce health care utilization, improve behavioral and social-emotional functioning, and treatment of mental health symptoms may result in improved HRQOL for patients with CHD.
Interventions that may Preserve or Improve Quality of Life
Individuals with CHD are at increased risk for differences in development, academic, and psychosocial functioning. Despite the risk of poor physical, neurodevelopmental, and/or psychosocial outcomes in individuals with CHD being well documented, understanding of how to mitigate those risks in individuals with CHD is still limited [38]. The primary aim of this review will be to present research related to interventions that could help preserve or restore physical functioning, neurodevelopment, and/or psychosocial wellness to promote and protect HRQOL in children and adolescents with CHD. We will consider interventions focused on the surgical and perioperative period, social and family context, and development and academic functioning. Many of the difficulties faced by children and adolescents with CHD are also described in other medical populations, so we also review interventions that have been effective in addressing neurodevelopmental and psychosocial concerns in other medical groups when CHD-specific literature is unavailable. Table 1 summarizes interventions described below.
Individualized Family-Centered Neurodevelopmental Care
Individualized family-centered neurodevelopmental care practices aim to minimize the mismatch between what the developing brain needs and the hospital environment by observing infant behavior and making modifications to the environment and/or caregiving to meet the needs of the infant [38]. Neurodevelopmental care is recognized as the best practice for medically fragile infants (e.g., premature and/or required neonatal surgical intervention), but implementation in pediatric cardiac intensive care units (ICU) is limited compared to neonatal ICUs [67]. There is an evidence-based developmental care program, Neonatal Individualized Developmental Care and Assessment Program (NIDCAP), which has been shown to reduce length of stay and improve physiological functioning, long-term neurodevelopment, parent confidence, and family satisfaction among premature infants [39,40,41,42]. Despite recent recognition of the importance of implementing neurodevelopmental care practices with the CHD population [38], there are no studies looking at the efficacy of NIDCAP or another comprehensive neurodevelopmental care intervention program in the pediatric cardiac ICU setting or with CHD patients. Individual components of neurodevelopmental care like skin-to-skin contact, developmental care rounds, cue-based care, family support, and education for providers, have been associated with improved developmental outcomes for patients with CHD and may improve HRQOL as well. [43, 44, 68,69,70,71,72,73].
To make implementation of neurodevelopmental care easier and to reduce variation in care practices, the Cardiac Newborn Neuroprotective Network, a special interest group of the Cardiac Neurodevelopmental Outcome Collaborative (CNOC), outlined an evidence-based developmental care pathway for infants hospitalized with CHD [67]. The neurodevelopmental care pathway includes recommendations for standardized developmental assessment, monitoring of parental mental health, and implementation of a daily developmental care bundle. The working group acknowledges that research to support these neurodevelopmental care interventions within the CHD population is limited but did highlight cardiac specific research related to benefits of skin-to-skin holding [43], reduced postoperative pain through infant massage [44], and reduced cardiopulmonary instability with two-person caregiving [67]. Evidence from other high-risk populations is cited for interventions where cardiac-specific research is unavailable. A comprehensive review of recommended interventions can be found in the published developmental care pathway [67]. Briefly, neurodevelopmental care intervention recommendations include: 1) monitoring of infant behavioral state with clustering of care based on infant needs; 2) prioritizing non-pharmacologic approaches to pain management when possible; 3) managing environmental stimuli with awareness of lights, sounds, and touch; 4) development and motor supports through proper positioning, passive range of motion, and prone positioning; 5) feeding interventions to prevent oral aversion, providing nutrition by mouth once appropriate, and supporting the use of human milk; 6) promoting parental presence through touch, holding, and participation in care; and 7) preparation for the eventual transition home.
Early Intervention
Neurobehavioral abnormalities have been identified pre- and post-operatively for infants with CHD who require surgical intervention in the first year of life [6, 7], establishing the need for early rehabilitative interventions like physical therapy, occupational therapy, and speech or feeding therapy. Early Intervention (EI) services provide comprehensive developmental services with the goal of preventing, delaying, or reducing the developmental impact of risk factors for children from birth to age three [74]. In the United States, EI is a federal grant program that is managed at the state level to provide free or low-cost developmental services for infants and toddlers who meet criteria (e.g., documentation of developmental delay, 1.5 standard deviations below the mean for age), which also varies by state.
EI to support developmental milestone attainment is particularly important, as gross motor ability is an early predictor of HRQOL, executive functioning, and mood [75]. Many children with CHD need rehabilitative therapies after surgical intervention or prolonged hospitalization, but EI services remain underutilized by eligible cardiac patients [74]. Though not well studied in children with CHD, past research has established that high-quality, high-frequency early childhood developmental services are effective in other high-risk patient populations like very low birthweight infants [45, 46]. In infants and toddlers with CHD, physical therapy started in the early postoperative period has been shown to promote gross motor recovery [47], and rehabilitation delivered through a 10-week program of parent-led developmental activities has also been shown to help children with CHD increase rates of developmental progress to meet age-appropriate levels [48]. Although EI services are beneficial, utilization rates remain low for all eligible children, including those with CHD [49].
No studies have investigated the impact of EI on HRQOL with cardiac patients, but optimizing developmental outcome and functional status is likely to improve HRQOL in turn. This idea is supported by decades worth of research with other high-risk populations who received prenatal and infancy home visits by nurses, which were shown to improve cognitive, academic, behavioral, and sociodemographic outcomes for children in these programs [76]. Identification of eligible individuals with CHD and referral to appropriate services is likely an easy intervention to implement.
Evidence-Based Psychological & Behavioral Interventions
Individuals with CHD have a higher prevalence of emotional, behavioral, and social difficulties than their heart healthy peers [77]. Children with single ventricle anatomy have been found to have a 65% lifetime prevalence of having a psychiatric disorder, with a 5 times higher lifetime rate of anxiety disorders and 6 times higher lifetime rate of attention-deficit/hyperactivity disorder (ADHD) than the general population [78]. Despite high rates of mental health concerns, few children and adolescents with CHD participate in psychological assessment or treatment [50]. Interventions (e.g., parent management training, cognitive behavioral therapy, acceptance and commitment therapy, trauma-focused therapy, mindfulness-based interventions) addressing areas of concern commonly reported by individuals with CHD (e.g., behavior concerns, anxiety, depression, posttraumatic stress, ADHD, procedural anxiety, coping with medical illness) have been developed and established as effective with non-CHD populations [38], but CHD-specific research is still lacking.
A recent systematic review on psychological interventions for individuals with CHD only identified nine unique interventions targeting children and adolescents with CHD or their mothers [14]. Of the CHD-specific interventions that have been studied, common intervention components include psychoeducation, supportive counseling, relaxation skill training, mindfulness-based stress reduction, and problem-solving skill development. Adolescents with CHD reported a decline in stress after attending six weeks of mindfulness training, which included yoga, meditation, cognitive restructuring and group support [51]. An intervention targeting mothers of children with CHD reported improvements in maternal mental health and family functioning after providing two educational workshops on how to address general developmental challenges and CHD-specific concerns, having mothers observe their child engage in exercise, and one individual follow up session [52, 53]. Unfortunately, an expansion of this intervention to include CHD patients themselves did not show differences in emotional and behavioral concerns at follow-up [54]. Finally, a psychoeducation and coping skills intervention was found to be effective in reducing symptoms of maladjustment post-surgery for patients with CHD [55]. The limited data available for review highlights the urgent need for psychological intervention research in children and adolescents with CHD. It will be important to consider how to leverage technology to provide education and interventions in modalities that are more accessible to patients and their families (e.g., telehealth, video conferencing, social media).
Physical Activity & Exercise Capacity
Overall, individuals with CHD have lower levels of daily physical activity and reduced levels of fitness compared to healthy peers [79,80,81,82]. The benefits of regular exercise are well documented for the general population, but physical activity and fitness are also important for individuals with CHD as activity and fitness level are associated with future outcomes [83,84,85,86]. In 2013, the American Heart Association [87] recommended regular physical activity for children and adults with CHD, as exercise intolerance or a sedentary lifestyle may put children with CHD at additional risk of developing comorbidities including obesity, diabetes, and symptoms of anxiety and depression [88]. In a recent review paper that included 3,256 patients with CHD, exercise training was shown to improve exercise capacity, physical activity, motoric skills, muscular function, and QOL [56]. The impact of exercise training on HRQOL was mixed across studies, with some finding improved HRQOL regardless of whether physical fitness improved [57,58,59,60,61], while others noted no change in HRQOL [62, 63], though this also varied by parent- versus patient-reported HRQOL [64]. Though the research is limited, summer camps for individuals with CHD have been shown to positively impact self-perceptions of physical functioning, self-esteem, and general behavior [65].
Education Related Interventions
Neurodevelopmental impairment is linked to poor educational outcomes for children with CHD, which can limit final educational attainment, employment, lifelong earnings, and HRQOL [6, 7]. Specifically, individuals with cCHD perform worse than norms on measures of intellectual and executive functioning, with notable levels of impairment in the area of metacognition [89]. School competency and school-related QOL is also lower in individuals with cCHD [89]. Utilization of special education services is high among students with CHD [90], but schools do not always recognize the challenges some patients with CHD face, or implement recommended academic supports from hospital-administered neuropsychological assessments [91]. Effective advocacy to ensure that children with CHD receive all appropriate school-based services and accommodations has the potential to improve educational attainment and HRQOL long-term.
School-liaison programs, or hospital-based educational advocates, can bridge the gap between the medical team and school. This type of programing is the standard of care in pediatric cancer and has been shown to be effective in promoting access to services and is associated with parental satisfaction [92]. While not the standard of care within pediatric cardiology, past research supports the benefit of a school-liaison program for cardiac patients. In a cohort of 61 patients, only 13 (21%) had educational plans prior to review by the school-liaison program. New or expanded educational plans were needed by 58 (95%) of patients, and the school-liaison program was able to accomplish this for 56 out of the 58 patients (97%) [92]. Further research will be needed to understand the impact of appropriate educational services on long-term neurodevelopmental outcomes and HRQOL.
Family Support
A recent systematic review found that over 80% of parents of children with CHD report clinically significant symptoms of post-traumatic stress, 30–80% report severe psychological distress, and 25–50% report symptoms of depression and/or anxiety [93]. Parental mental health is a strong predictor of child development outcomes, even more so than medical variables [94, 95], highlighting how intervention focused on parental adaptation may also positively impact child neurodevelopmental and HRQOL outcomes [66]. While there is increasing recognition of the importance of supporting parental mental health and family functioning for families of children with CHD, published research has not established evidence related to the most effective type of treatment, timing of treatment, or mode of delivery [66].
Two systematic reviews [14, 96] found seven unique intervention studies for parents of children with CHD. Across these studies, the therapeutic approach of parent focused interventions varied widely (e.g., education and parenting skills training, parent-infant interaction and bonding, early pediatric palliative care). Tested interventions were successful in reducing maternal anxiety and improving maternal coping, mother-infant attachment, parenting confidence, satisfaction with care, and infant cognitive development at 6 months [96]. Results were mixed for maternal depression and infant feeding, and there was no evidence that interventions improved parent, infant, or family HRQOL. There has also been qualitative work looking at parent preferences for psychosocial intervention, which found that parents want direct management of parent mental health symptoms, peer support provided by other experienced parents, education on how to effectively communicate with medical teams and advocate for their child’s needs, and education about how to partner in their child’s medical and developmental care [97].
Future Directions
Advancements in HRQOL measurement through the creation of reliable, valid, and generalizable measures has allowed a more thorough understanding of HRQOL-related outcomes in patients with CHD. Despite this, there continues to be a dearth of literature exploring the relationships between HRQOL and neurodevelopmental, psychosocial, and physical morbidity factors [29]. Better characterization of these relationships will help identify specific factors that may be improved through modification of current care and/or the development of targeted interventions. High quality intervention research using appropriate HRQOL instruments is needed across neurodevelopmental, psychosocial, and physical domains for patients with CHD. Outcomes should include both the intervention target (e.g., physical, psychological, social, education attainment) and HRQOL for the most comprehensive understanding of the impact of the intervention. Utilizing outcome measures recommended by the International Consortium for Health Outcomes Measurement (ICHOM) CHD working group would allow for easier comparison of intervention effects and outcomes across studies [98]. It is also important that intervention research allows for both short- and long-term follow-up to understand the effectiveness of interventions over time. Careful consideration should be given to the timing of and duration of any studied intervention as these two factors may significantly impact the effectiveness of any given intervention.
Conclusions
CHD-related morbidities have been well documented, but there has been little focus on ways to mitigate poor outcomes and HRQOL. Neurodevelopmental, psychosocial, and physical functioning related intervention research with CHD patients is still limited, but there are promising data to support the potentially positive impact of targeted interventions. It is critical to investigate the effectiveness of existing evidence-based interventions with cardiac patients (e.g., cognitive behavioral therapy for anxiety) and identify where and when cardiac-specific interventions need to be modified from other pediatric populations or developed. Routine measurement of HRQOL from patient and parent perspectives will be an important component to stratify which patients may benefit from intervention and whether interventions are effective in the short- and long-term. Effective interventions have the potential to profoundly impact neurodevelopmental, psychosocial, and physical outcomes and HRQOL of individuals with CHD across the lifespan.
Data Availability
No datasets were generated or analysed during the current study.
References
Van Der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58(21):2241–7.
Hoffman J, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.
Green A. Outcomes of congenital heart disease: a review. Pediatr Nurs. 2004;30(4):280.
Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502–8.
Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW. Brain in congenital heart disease across the lifespan: the cumulative burden of injury. Circulation. 2016;133(20):1951–62.
Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012;126(9):1143–72.
Sood E, Newburger JW, Anixt JS, Cassidy AR, Jackson JL, Jonas RA, Lisanti AJ, Lopez KN, Peyvandi S, Marino BS. American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young and the Council on Cardiovascular and Stroke Nursing. Neurodevelopmental outcomes for individuals with congenital heart disease: updates in neuroprotection, risk-stratification, evaluation, and management: a scientific statement from the American Heart Association. Circulation. 2024;149(13):e997-1022.
Simko LC, McGinnis KA. Quality of Life Experienced by Adults with Congenital Heart Disease. AACN Clinic Issues. 2003;14:42–53.
Ryan KR, Jones MB, Allen KY, Marino BS, Casey F, Wernovsky G, et al. Neurodevelopmental outcomes among children with congenital heart disease: at-risk populations and modifiable risk factors. World J Pediatr Congenit Heart Surg. 2019;10(6):750–8.
Majnemer A, Limperopoulos C, Shevell M, Rosenblatt B, Rohlicek C, Tchervenkov C. Long-term neuromotor outcome at school entry of infants with congenital heart defects requiring open-heart surgery. J Pediatr. 2006;148(1):72–7.
Marino BS, Cassedy A, Drotar D, Wray J. The impact of neurodevelopmental and psychosocial outcomes on health-related quality of life in survivors of congenital heart disease. J Pediatr. 2016;1(174):11–22.
Wilson WM, Smith-Parrish M, Marino BS, Kovacs AH. Progress in Pediatric Cardiology neurodevelopmental and psychosocial outcomes across the congenital heart disease lifespan. Prog Pediatr Cardiol. 2015;39(2):113–8.
Calderon J, Bellinger DC. Executive function deficits in congenital heart disease: why is intervention important? Cardiol Young. 2015;25(7):1238–46.
Tesson S, Butow PN, Sholler GF, Sharpe L, Kovacs AH, Kasparian NA. Psychological interventions for people affected by childhood-onset heart disease: A systematic review. Health Psychol. 2019;38(2):151.
Ware JE Jr. Methodology in behavioral and psychosocial cancer research. Conceptualizing disease impact and treatment outcomes. Cancer. 1984;53(10):2316–26.
Aaronson NK. Quality of life: what is it? How should it be measured? Oncology (Williston Park). 1988;2(5):69–76.
Drotar D. Measuring Child Health: Scientific Questions, Challenges, and Recommendations. Ambul Pediatr. 2004;4(4):353–7.
Drotar D. Measuring health-related quality of life in children and adolescents. Publishers, Mahwah NJ: Lawrence Erlbaum Associates; 1998.
Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ. 2001;322:1297–300.
Moons P, Van Deyk K, Budts W, De Geest S. Caliber of quality-of-life assessments in congenital heart disease: a plea for more conceptual and methodological rigor. Arch Pediatr Adolesc Med. 2004;158(11):1062–9.
Drakouli M, Petsios K, Giannakopoulou M, Patiraki E, Voutoufianaki I, Matziou V. Determinants of quality of life in children and adolescents with CHD: a systematic review. Cardiol Young. 2015;25(6):1027–36.
Kamphuis M, Zwinderman KH, Vogels T, et al. A cardiac-specific health-related quality of life module for young adults with congenital heart disease: Development and validation. Qual Life Res. 2004;13(4):735–45.
Kendall L, Lewin RJ, Parsons JM, Veldtman GR, Quirk J, Hardman GE. Factors associated with self-perceived state of health in adolescents with congenital cardiac disease attending paediatric cardiologic clinics. Cardiol Young. 2001;11(4):431–8.
Landgraf JM, Abezt L, Ware JE. The Child Health Questionnaire (CHQ): A user’s manual. 1st ed. Boston: The Health Institute, New England Medical Center; 1996.
Macran S, Birks Y, Parsons J, et al. The development of a new measure of quality of life for children with congenital cardiac disease. Cardiol Young. 2006;16(2):165–72.
Marino BS, Shera D, Wernovsky G, et al. The development of the pediatric cardiac quality of life inventory: a quality of life measure for children and adolescents with heart disease. Qual Life Res. 2008;17(4):613–26.
Uzark K, Jones K, Burwinkle TM, Varni JW. The Pediatric Quality of Life Inventory™ in children with heart disease. Prog Pediatr Cardiol. 2003;18(2):141–9.
Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126–39.
Marino BS, Cassedy A, Wray J. Evaluation of quality of life in children and adolescents with congenital and acquired heart disease. In: Shaddy RE, Penny DJ, Feltes TF, Cetta F, Mital S, editors. Moss & Adams’ Heart Disease in infants, Children, and Adolescents: Including the Fetus and Young Adult. 10th Ed. 10th Edition. Williams & Wilkins: Lippincott; 2022.
Latal B, Helfricht S, Fischer JE, Bauersfeld U, Landolt MA. Psychological adjustment and quality of life in children and adolescents following open-heart surgery for congenital heart disease: a systematic review. BMC Pediatr. 2009;9:6.
Mellion K, Uzark K, Cassedy A, Drotar D, Wernovsky G, Newburger JW, et al. Health-related quality of life outcomes in children and adolescents with congenital heart disease. J Pediatr. 2014;164:781-8.e1.
Mussatto K, Tweddell J. Quality of life following surgery for congenital cardiac malformations in neonates and infants. Cardiol Young. 2005;15(Suppl 1):174–8.
Marino BS, Tomlinson RS, Wernovsky G, Drotar D, Newburger JW, Mahony L, et al. Validation of the pediatric cardiac quality of life inventory. Pediatrics. 2010;126:498–508.
Wray J, Franklin R, Brown K, Cassedy A, Marino BS. Testing the pediatric cardiac quality of life inventory in the United kingdom. Acta Paediatr. 2013;102(2):e68-73.
Uzark K, Jones K, Slusher J, Limbers CA, Burwinkle TM, Varni JW. Quality of life in children with heart disease as perceived by children and parents. Pediatrics. 2008;121:e1060–7.
O’Connor AM, Cassedy A, Wray J, Brown KL, Cohen M, Franklin RCG, et al. Differences in Quality of Life in Children Across the Spectrum of Congenital Heart Disease. JPeds. 2023;263:113701.
Ernst MM, Marino BS, Cassedy A, et al. Biopsychosocial Predictors of Quality of Life Outcomes in Pediatric Congenital Heart Disease. Pediatr Cardiol. 2018;39(1):79–88.
Cassidy AR, Butler SC, Briend J, et al. Neurodevelopmental and psychosocial interventions forindividuals with congenital heart disease: A research agenda and recommendations from the CNOC. Cardiol Young. 2021;31(6):888–99.
Als H. Program guide—Newborn individualized developmental care and assessment program (NIDCAP): An education and training program for health care professionals. Boston: Copyright, NIDCAP Federation International; 1986.
Als H, Lawhon G, Duffy FH, Mcanulty GB, Gibes-Grossman R. Blickman JG Individualized Developmental Care for the Very Low - Birth – Weight Preterm Infant Medical and Neurofunctional Effects. J Am Med Assoc. 1994;272:853–8. https://doi.org/10.1001/jama.272.11.853.
Als H, Gilkerson L, Duffy FH, et al. A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: Medical, neurodevelopmental, parenting, and caregiving effects. J Dev Behav Pediatr. 2003;24:399–408. https://doi.org/10.1097/00004703-200312000-00001.
Als H, Duffy FH, McAnulty GB, et al. Early Experience Alters Brain Function and Structure. Pediatrics. 2004;113:846–57. https://doi.org/10.1542/peds.113.4.846.
Lisanti AJ, Demianczyk AC, Costarino A, et al. Skin-to-skin care is a safe and effective comfort measure for infants before and after neonatal cardiac surgery. Pediatr Crit Care Med. 2020;21:e834–41. https://doi.org/10.1097/PCC.0000000000002493.
Harrison TM, Brown R, Duffey T, et al. Effects of massage on postoperative pain in infants with complex congenital heart disease. Nurs Res 2020; S36–S46. https://doi.org/10.1097/NNR.0000000000000459
Nores M. Barnett WS Benefits of early childhood interventions across the world: (Under) Investing in the very young. Econ Educ Rev. 2010;29:271–82.
Majnemer A. Benefits of early intervention for children with developmental disabilities. Semin Pediatr Neurol. 1998;5:62–9. https://doi.org/10.1016/S1071-9091(98)80020-X.Ware. (etal. 2020 CNOC birth to 5 battery).
Haseba S, Sakakima H, Nakao S, Ohira M, Yanagi S, Imoto Y, Yoshida A, Shimodozono M. Early postoperative physical therapy for improving short-term gross motor outcome in infants with cyanotic and acyanotic congenital heart disease. Disabil Rehabil. 2018;40(14):1694–701.
Stieber NA, Gilmour S, Morra A, Rainbow J, Robitaille S, Van Arsdell G, McCrindle BW, Gibson BE, Longmuir PE. Feasibility of improving the motor development of toddlers with congenital heart defects using a home-based intervention. Pediatr Cardiol. 2012;33:521–32.
Mussatto K, Hollenbeck-Pringle D, Trachtenberg F, Sood E, Sananes R, Pike NA, Pemberton VL. Utilisation of early intervention services in young children with hypoplastic left heart syndrome. Cardiol Young. 2018;28(1):126–33.
Loccoh EC, Yu S, Donohue J, Lowery R, Butcher J, Pasquali SK, Goldberg CS, Uzark K. Prevalence and risk factors associated with non-attendance in neurodevelopmental follow-up clinic among infants with CHD. Cardiol Young. 2018;28:554–60. https://doi.org/10.1017/S1047951117002748.
Freedenberg VA, Hinds PS, Friedmann E. Mindfulness-based stress reduction and group support decrease stress in adolescents with cardiac diagnoses: A randomized two-group study. Pediatr Cardiol. 2017;38(7):1415–25.
McCusker CG, Doherty NM, Molloy B, Rooney N, Mulholland C, Sands A, Casey F. A randomized controlled trial of interventions to promote adjustment in children with congenital heart disease entering school and their families. J Pediatr Psychol. 2012;37(10):1089–103.
McCusker CG, Doherty NM, Rooney N, Mulholland C, Craig B, Stewart M, Casey F. A controlled trial of early interventions to promote maternal adjustment and development in infants born with severe congenital heart disease. Child: Care, Health, and Development. 2010;36(1):110–7.
van der Mheen M, Meentken MG, van Beynum IM, van der Ende J, Zirar A, Aendekerk EWC, Utens EM. CHIP-Family intervention to improve the psychosocial wellbeing of young children with congenital heart disease and their families: Results of a randomized controlled trial. Cardiol Young. 2019;29(9):1172–82.
Campbell LA, Kirkpatrick SE, Berry CC, Lamberti JJ. Preparing children with congenital heart disease for cardiac surgery. J Pediatr Psychol. 1995;20(3):313–28.
Dold SK, Haas NA, Apitz C. Effects of Sports, Exercise Training, and Physical Activity in Children with CHD – A Review of the Published Evidence. Children. 2023;10:296.
Duppen N, Etnel JR, Spaans L, Takken T, van den Berg-Emons RJ, Boersma E, Schokking M, Dulfer K, Utens EM, Helbing W, et al. Does exercise training improve cardiopulmonary fitness and daily physical activity in children and young adults with corrected tetralogy of Fallot or Fontan circulation? A randomized controlled trial. Am Heart J. 2015;170:606–14.
Dulfer K, Duppen N, Blom NA, van Dijk AP, Helbing WA, Verhulst FC, Utens EM. Effect of exercise training on sports enjoyment and leisure-time spending in adolescents with complex congenital heart disease: The moderating effect of health behavior and disease knowledge. Congenit Heart Dis. 2014;9:415–23.
Dulfer K, Duppen N, Blom NA, Van Domburg RT, Helbing WA, Verhulst FC, Utens EMWJ. Effects of exercise training on behavioral and emotional problems in adolescents with tetralogy of Fallot or a Fontan circulation: A randomized controlled trial. Int J Cardiol. 2014;172:e425–7.
Kroll KH, Kovach JR, Ginde S, Jacobsen RM, Danduran M, Foster A, Brosig CL. Impact of a paediatric cardiac rehabilitation programme upon patient quality of life. Cardiol Young. 2021;31:804–11.
Sutherland N, Jones B, Westcamp Aguero S, Melchiori T, du Plessis k, Konstantinov IE, Cheung MMH, D’udekem Y. Home- and hospital-based exercise training programme after Fontan surgery. Cardiol Young. 2018;28:1299–305.
Meyer M, Brudy L, Fuertes-Moure A, Hager A, Oberhoffer-Fritz R, Ewert P, Müller J. E-Health Exercise Intervention for Pediatric Patients with Congenital Heart Disease: A Randomized Controlled Trial. J Pediatr. 2021;233:163–8.
Hedlund ER, Lundell B, Söderström L, Sjöberg G. Can endurance training improve physical capacity and quality of life in young Fontan patients? Cardiol Young. 2018;28:438–46.
Jacobsen RM, Ginde S, Mussatto K, Neubauer J, Earing M, Danduran M. Can a Home-based Cardiac Physical Activity Program Improve the Physical Function Quality of Life in Children with Fontan Circulation? Congenit Heart Dis. 2016;11:175–82.
Moons P, Barréa C, De Wolf D, Gewillig M, Massin M, Mertens L, Ovaert C, Suys B, Sluysmans T. Changes in perceived health of children with congenital heart disease after attending a special sports camp. Pediatr Cardiol. 2006;27:67–72.
Sood E, Lisanti AJ, Woolf-King SE, Wray J, Kasparian N, Jackson E, Gregory MR, Lopez KN, Marino BS, Neely T, Randall A. Parent mental health and family functioning following diagnosis of CHD: A research agenda and recommendations from the Cardiac Neurodevelopmental Outcome Collaborative. Cardiol Young. 2021;31(6):900–14.
Lisanti AJ, Vittner DJ, Peterson J, Van Bergen AH, Miller TA, Gordon EE, Negrin KA, Desai H, Willette S, Jones MB, Caprarola SD. Developmental care pathway for hospitalised infants with CHD: on behalf of the Cardiac Newborn Neuroprotective Network, a Special Interest Group of the Cardiac Neurodevelopmental Outcome Collaborative. Cardiol Young. 2023;33(12):2521–38.
Butler SC, Huyler K, Kaza A, Rachwal C. Filling a significant gap in the cardiac ICU: implementation of individualised developmental care. Cardiol Young Published online 2017: 1–10. https://doi.org/10.1017/S1047951117001469.
Miller TA, Lisanti AJ, Witte MK, et al. A Collaborative Learning Assessment of Developmental Care Practices for Infants in the Cardiac Intensive Care Unit. J Pediatr Published online. 2020. https://doi.org/10.1016/j.jpeds.2020.01.043.
Sood E, Berends WM, Butcher JL, et al. Developmental Care in North American Pediatric Cardiac Intensive Care Units: survey of Current Practices. Adv Neonatal Care. 2016;16:211–9. https://doi.org/10.1097/ANC.0000000000000264.Developmental.
Lisanti AJ, Vittner D, Medoff-Cooper B, Fogel J, Wernovsky G, Butler S. Individualized Family-Centered Developmental Care. J Cardiovasc Nurs 2018; 1. https://doi.org/10.1097/JCN.0000000000000546.
Peterson JK. Evangelista LS Developmentally Supportive Care in Congenital Heart Disease: A Concept Analysis. J Pediatr Nurs. 2017;36:1–7. https://doi.org/10.1016/j.pedn.2017.05.007.
Peterson JK. Supporting optimal neurodevelopmental outcomes in infants and children with congenital heart disease. Crit Care Nurse. 2018;38:68–74.
Ware J, Butcher JL, Latal B, Sadhwani A, Rollins CK, Soto CL, Butler SC, Eiler-Sims PB, Shade CV, Wernovsky G. Neurodevelopmental evaluation strategies for children with congenital heart disease aged birth through 5 years: recommendations from the cardiac neurodevelopmental outcome collaborative. Cardiol Young. 2020;30(11):1609–22.
Marino, B. S., Beebe, D. W., Cassedy, A., Riedel, M., Burger, M., Medek, S., . . . Drotar, D. (2011). Executive functioning, gross motor ability and mood are key drivers of poorer quality of life in child and adolescent survivors with complex congenital heart disease. Journal of the American College of Cardiology, 57(4). https://doi.org/10.1016/S0735-1097(11)60421-X
Eckenrode J, Campa M, Luckey DW, et al. Long-term Effects of Prenatal and Infancy Nurse Home Visitation on the Life Course of Youths. Arch Pediatr Adolesc Med. 2010;164:9–16. https://doi.org/10.1001/archpediatrics.2009.240.
Kovacs AH, Brouillette J, Ibeziako P, Jackson JL, Kasparian NA, Kim YY, Livecchi T, Sillman C, Kochilas LK. American Heart Association Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council. Psychological outcomes and interventions for individuals with congenital heart disease: a scientific statement from the American Heart Association. Circulation: Cardiovascular Quality and Outcomes. 2022;15(8):e000110.
DeMaso DR, Calderon J, Taylor GA, Holland JE, Stopp C, White MT, Bellinger DC, Rivkin MJ, Wypij D, Newburger JW. Psychiatric disorders in adolescents with single ventricle congenital heart disease. Pediatrics. 2017;139:e20162241. https://doi.org/10.1542/peds.2016-2241.
Brudy L, Hock J, Häcker AL, Meyer M, Oberhoffer R, Hager A, Ewert P, Müller J. Children with congenital heart disease are active but need to keep moving: a cross-sectional study using wrist-worn physical activity trackers. J Pediatr. 2020;1(217):13–9.
Dua JS, Cooper AR, Fox KR, Stuart AG. Physical activity levels in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2007;14(2):287–93.
McCrindle BW, Williams RV, Mital S, Clark BJ, Russell JL, Klein G, Eisenmann JC. Physical activity levels in children and adolescents are reduced after the Fontan procedure, independent of exercise capacity, and are associated with lower perceived general health. Arch Dis Child. 2007;92:509–14.
Sandberg C, Pomeroy J, Thilén U, Gradmark A, Wadell K, Johansson B. Habitual physical activity in adults with congenital heart disease compared with age-and sex-matched controls. Can J Cardiol. 2016;32(4):547–53.
Dimopoulos K, Okonko DO, Diller GP, Broberg CS, Salukhe TV, BabuNarayan SV, Li W, Uebing A, Bayne S, Wensel R, Piepoli MF, PooleWilson PA, Francis DP, Gatzoulis MA. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation. 2006;113:2796–802.
Giardini A, Hager A, Lammers AE, Derrick G, Müller J, Diller GP, Dimopoulos K, Odendaal D, Gargiulo G, Picchio FM, Gatzoulis MA. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J Am Coll Cardiol. 2009;53:1548–55.
Müller J, Ewert P, Hager A. Only slow decline in exercise capacity in the natural history of patients with congenital heart disease: a longitudinal study in 522 patients. Eur J Prev Cardiol. 2015;22(1):113–8.
Udholm S, Aldweib N, Hjortdal VE, Veldtman GR. Prognostic power of cardiopulmonary exercise testing in Fontan patients: a systematic review. Open Heart. 2018;5(1):e000812.
Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013;128(8):873–934.
West SL, Banks L, Schneiderman JE, Caterini JE, Stephens S, White G, Dogra S, Wells GD. Physical activity for children with chronic disease; a narrative review and practical applications. BMC Pediatr. 2019;19:12.
Gerstle M, Beebe DW, Drotar D, Cassedy A, Marino BS. Executive functioning and school performance among pediatric survivors of complex congenital heart disease. J Pediatr. 2016;173:154–9.
Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics. 2008;121(4):e759–67.
Brosig C, Yang K, Hoffmann RG, Dasgupta M, Mussatto K. The role of psychology in a pediatric outpatient cardiology setting: preliminary results from a new clinical program. J Clin Psychol Med Settings. 2014;21:337–46.
Ruehl CA, Landry KK, Stoiber KC, Brosig CL. Building a cardiac Educational Achievement Partnership Program: examination of implementation. Circulation: Cardiovascular Quality and Outcomes. 2022;15(4):e008531.
Woolf-King SE, Anger A, Arnold EA, Weiss SJ, Teitel D. Mental health among parents of children with critical congenital heart defects: a systematic review. J Am Heart Assoc. 2017;6(2):e004862.
DeMaso DR, Labella M, Taylor GA, Forbes PW, Stopp C, Bellinger DC, Rivkin MJ, Wypij D, Newburger JW. Psychiatric disorders and function in adolescents with d-transposition of the great arteries. J Pediatr. 2014;165(4):760–6.
McCusker CG, Armstrong MP, Mullen M, Doherty NN, Casey FA. A sibling-controlled, prospective study of outcomes at home and school in children with severe congenital heart disease. Cardiol Young. 2013;23(4):507–16.
Kasparian NA, Kan JM, Sood E, Wray J, Pincus HA, Newburger JW. Mental health care for parents of babies with congenital heart disease during intensive care unit admission: Systematic review and statement of best practice. Early Human Dev. 2019;1(139):104837.
Gramszlo C, Karpyn A, Demianczyk AC, Shillingford A, Riegel E, Kazak AE, Sood E. Parent perspectives on family-based psychosocial interventions for congenital heart disease. J Pediatr. 2020;1(216):51–7.
Hummel K, Whittaker S, Sillett N, Basken A, Berghammer M, Chalela T, Chauhan J, Garcia LA, Hasan B, Jenkins K, Ladak LA. Development of an international standard set of clinical and patient-reported outcomes for children and adults with congenital heart disease: a report from the International Consortium for Health Outcomes Measurement Congenital Heart Disease Working Group. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):354–65.
Author information
Authors and Affiliations
Contributions
All authors drafted the work or revised it critically for important intellectual content; approved the version to be published; and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Human and Animal Rights
This article does not contain any studies with human or animal subjects performed by any of the authors.
Financial and Non-Financial Competing Interests
The authors declare that they have no competing interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Demianczyk, A.C., Marshall, M., Rao, R. et al. Optimizing Quality of Life in Children with Complex Congenital Heart Disease. Curr Treat Options Peds (2024). https://doi.org/10.1007/s40746-024-00303-7
Accepted:
Published:
DOI: https://doi.org/10.1007/s40746-024-00303-7